sRAGE is Elevated in Septic Patients and Associated With Patients Outcome

Journal of Surgical Research

Volumn 147, Issue 1, 2008, Pages 79-83

  Bopp, Christian ^a   Hofer, Stefan ^a   Weitz, Jürgen ^a   Bierhaus, Angelika ^a   Nawroth, Peter P ^a   Martin, Eike ^a   Büchler, Markus W ^a   Weigand, Markus A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

clinical trail; sepsis; sepsis markers; septic shock; severe sepsis; sRAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; INTENSIVE CARE UNIT; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK;

ADULT; AGED; BIOLOGICAL MARKERS; HUMANS; MIDDLE AGED; NF-KAPPA B; RECEPTORS, IMMUNOLOGIC; SEPSIS;

EID: 43049145039     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.07.014     Document Type: Article

References (19)

1. Angus D.C., Pereira C.A., and Silva E. Epidemiology of severe sepsis around the world. Endocr Metab Immune Dis Drug Targets 6 (2006) 207
2. Bierhaus A., Stern D.M., and Nawroth P.P. RAGE in inflammation: A new therapeutic target?. Curr Opin Invest Drugs 7 (2006) 985
3. Liliensiek B., Weigand M.A., Bierhaus A., et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest 113 (2004) 1641
4. Yamagishi S., Adachi H., Nakamura K., et al. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects. Metabolism 55 (2006) 1227
5. Koyama H., Shoji T., Yokoyama H., et al. Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 25 (2005) 2587
6. Bone R.C., Balk R.A., Cerra F.B., et al. ACCP/SCCM consensus conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101 (1992) 1644
7. Marshall J.C., Vincent J.L., Fink M.P., et al. Measures, markers, and mediators: Toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25 and 26, 2000. Crit Care Med 31 (2003) 1560
8. Roch A., Allardet-Servent J., Michelet P., et al. NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 33 (2005) 1001
9. Gibot S., Cravoisy A., Kolopp-Sarda M.N., et al. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 33 (2005) 792
10. Gibot S., Kolopp-Sarda M.N., Bene M.C., et al. Plasma level of a triggering receptor expressed on myeloid cells-1: Its diagnostic accuracy in patients with suspected sepsis. Ann Int Med 141 (2004) 9
11. Scherpereel A., Depontieu F., Grigoriu B., et al. Endocan, a new endothelial marker in human sepsis. Crit Care Med 34 (2006) 532
12. Weigand M.A., Schmidt H., Pourmahmoud M., et al. Circulating intercellular adhesion molecule-1 as an early predictor of hepatic failure in patients with septic shock. Crit Care Med 27 (1999) 2656
13. Bohrer H., Qiu F., Zimmermann T., et al. Role of NFκB in the mortality of sepsis. J Clin Invest 100 (1997) 972
14. Li J., and Schmidt A.M. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 272 (1997) 16498
15. Raman K.G., Sappington P.L., Yang R., et al. The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 291 (2006) G556
16. Humpert P.M., Kopf S., Djuric Z., et al. Plasma sRAGE is independently associated with urinary albumin excretion in type 2 diabetes. Diabetes Care 29 (2006) 1111
17. Hudson B.I., Harja E., Moser B., et al. Soluble levels of receptor for advanced glycation end-products (sRAGE) and coronary artery disease: The next C-reactive protein?. Arterioscler Thromb Vasc Bio 25 (2005) 879
18. Yonekura H., Yamamoto Y., Sakurai S., et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 370 (2003) 1097
19. Kislinger T., Fu C., Huber B., et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274 (1999) 31740